Actavis Agrees to Buy Allergan for $66 Billion

Actavis said that it would pay $66 billion in cash and stock for Allergan in a deal aimed at thwarting a hostile takeover of the Botox maker.



from WSJ.com: US Business http://ift.tt/1H9qHYA

via IFTTT